These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 16644117)

  • 1. Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on BDNF mRNA expression in rat frontal cortex and hippocampus.
    Martínez-Turrillas R; Moyano S; Del Río J; Frechilla D
    Neurosci Lett; 2006 Jul; 402(1-2):126-30. PubMed ID: 16644117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rat frontal cortex but not in the hippocampus.
    García-Osta A; Del Río J; Frechilla D
    Brain Res Mol Brain Res; 2004 Jul; 126(2):181-7. PubMed ID: 15249142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat.
    Jacobsen JP; Mørk A
    Brain Res; 2006 Sep; 1110(1):221-5. PubMed ID: 16876769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated BDNF protein level in cortex but not in hippocampus of MDMA-treated Dark Agouti rats: a potential link to the long-term recovery of serotonergic axons.
    Adori C; Andó RD; Ferrington L; Szekeres M; Vas S; Kelly PA; Hunyady L; Bagdy G
    Neurosci Lett; 2010 Jul; 478(2):56-60. PubMed ID: 20435092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels.
    Jacobsen JP; Mørk A
    Brain Res; 2004 Oct; 1024(1-2):183-92. PubMed ID: 15451381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single dose of MDMA causes extensive decrement of serotoninergic fibre density without blockage of the fast axonal transport in Dark Agouti rat brain and spinal cord.
    Kovács GG; Andó RD; Adori C; Kirilly E; Benedek A; Palkovits M; Bagdy G
    Neuropathol Appl Neurobiol; 2007 Apr; 33(2):193-203. PubMed ID: 17359360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
    Kirilly E
    Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation between serotonin neurotoxicity and brain-derived neurotrophic factor induction following neonatal MDMA exposure in rats.
    Piper BJ; Farelli JD; Meyer JS
    Dev Neurosci; 2009; 31(1-2):90-4. PubMed ID: 19372690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns.
    Adori C; Andó RD; Kovács GG; Bagdy G
    J Comp Neurol; 2006 Jul; 497(2):251-69. PubMed ID: 16705678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants.
    Larsen MH; Hay-Schmidt A; Rønn LC; Mikkelsen JD
    Eur J Pharmacol; 2008 Jan; 578(2-3):114-22. PubMed ID: 17950272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A preliminary study on the mechanism of neurotoxicity of MDMA--oxidative stress harm].
    Li SX; Sun AM; Wang X; Li J; Peng ZG; Kuang WH; Huang MS
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):191-5. PubMed ID: 16608072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered gene expression in frontal cortex and midbrain of 3,4-methylenedioxymethamphetamine (MDMA) treated mice: differential regulation of GABA transporter subtypes.
    Peng W; Simantov R
    J Neurosci Res; 2003 Apr; 72(2):250-8. PubMed ID: 12672000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat.
    Koprich JB; Campbell NG; Lipton JW
    Brain Res Dev Brain Res; 2003 Dec; 147(1-2):177-82. PubMed ID: 14741762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of BDNF and TrkB expression in rat hippocampus in response to acute neurotoxicity by diethyldithiocarbamate.
    Micheli MR; Bova R; Laurenzi MA; Bazzucchi M; Grassi Zucconi G
    Neurosci Lett; 2006 Dec; 410(1):66-70. PubMed ID: 17052849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.
    Sprague JE; Nichols DE
    J Pharmacol Exp Ther; 1995 May; 273(2):667-73. PubMed ID: 7538579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3,4-Methylenedioxymethamphetamine increases pro-interleukin-1beta production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of Dark Agouti rats: role of interleukin-1beta in neurotoxicity.
    O'Shea E; Sanchez V; Orio L; Escobedo I; Green AR; Colado MI
    Neuroscience; 2005; 135(4):1095-105. PubMed ID: 16165281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
    Yeh SY
    Synapse; 1999 Mar; 31(3):169-77. PubMed ID: 10029234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.